Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 53
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

SANDOZ

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 49
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

HIKMA INTL PHARMS

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 50
  • 0 comments

FDA approve LISINOPRIL

Comment Full text

SANDOZ

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 48
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

MYLAN

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 57
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 46
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 15, 2024, 08:51 UTC
  • 49
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

MYCOVIA PHARMS

  • FDA Approval
  • April 12, 2024, 13:22 UTC
  • 49
  • 0 comments

FDA approve OTESECONAZOLE

Comment Full text

TARO

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 47
  • 0 comments

FDA approve ADAPALENE; BENZOYL PEROXIDE

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 50
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text
  • Previous
  • 478
  • 479
  • 480
  • 481
  • 482
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393624)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239501)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin